Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02570542
Title Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Nebraska Medical Center Omaha Nebraska 68198-7680 United States Details
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack (Consent and Follow-up Only) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Northwell Health (Data collection only) Manhasset New York 11030 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Columbia University New York New York United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
Memorial Sloan Kettering Nassau (Consent and Follow up Only) Uniondale New York 11553 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Texas Transplant Institute San Antonio Texas 78229 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field